STOCKSAbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis DrugBy Tony OwusuDec 3, 2019 10:06 AM EST
STOCKSMerck Wins Drug Approval and Part of a Court Case; Here's How to Trade the StockBy Jonas ElmerrajiNov 27, 2019 12:59 PM EST
MARKETSStocks End Higher as Trump Says Trade Deal with China 'Potentially Very Close'By Rob LenihanNov 22, 2019 4:18 PM EST
MARKETSDow Ends Above 28,000; Stocks at Records on Trade-Deal HopesBy Rob LenihanNov 15, 2019 4:26 PM EST
STOCKSPfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price TargetBy Tony OwusuNov 7, 2019 10:32 AM EST
EARNINGSMylan Posts Stronger-Than-Expected Third-Quarter Profit, Reiterates ForecastBy M. Corey GoldmanNov 5, 2019 9:35 AM EST
MARKETSFiat Chrysler, Fed, Apple, AMD, GE - 5 Things You Must Know WednesdayBy Joseph WoelfelOct 30, 2019 7:31 AM EDT
MARKETSDow Ends Lower; S&P 500 Slips After Intraday Record on Strong Pharma EarningsBy Rob LenihanOct 29, 2019 4:23 PM EDT
EARNINGSPfizer Tops Q3 Earnings Forecast, Boosts Full Year Profit Guidance: Shares GainBy Martin BaccardaxOct 29, 2019 10:28 AM EDT
STOCKSDow Futures Slide, S&P 500 Eases From Record Highs Ahead of Fed Rate MeetingBy Martin BaccardaxOct 29, 2019 8:51 AM EDT
MARKETSAlphabet, Federal Reserve, BP, Pfizer and AMD - 5 Things You Must KnowBy Joseph WoelfelOct 29, 2019 7:01 AM EDT
JIM CRAMERRallying on a Downside Surprise: Cramer's 'Mad Money' RecapBy Scott RuttOct 17, 2019 8:50 PM EDT
MARKETSDow Finishes Higher as Wall Street Bounces Back, Probability Climbs for Rate CutBy Rob LenihanOct 3, 2019 4:27 PM EDT
STOCKSPfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema DrugBy Martin BaccardaxSep 27, 2019 9:50 AM EDT
STOCKSExact Sciences Lifted to Buy at Benchmark on Wider Cologuard-Use ApprovalBy Rob DanielSep 23, 2019 10:23 AM EDT
INVESTINGAs U.S. Interest Rates Head Lower, Here's What To Invest InBy Jason OrestesSep 3, 2019 12:22 PM EDT
MARKETSDow Ends Higher as Wall Street Gets Boost From Gains in Energy SectorBy Rob LenihanAug 28, 2019 4:24 PM EDT
MARKETSStocks Fall as Recession Worries Resurface, Trade Concerns RemainBy Rob LenihanAug 27, 2019 4:30 PM EDT
